Drug Discovery V-Forum

Virtual Conference / Summit
Healthcare Clinical Trials

Date: 21 to 22 Apr '21
Time: From 12:30pm (GMT) Greenwich Mean Time: Dublin, Edinburgh, Lisbon, London

Visit Event Website


With a 7+ year history of bringing together the global research community to tackle the challenges that the discovery scientists face, World BI prides itself on organizing Drug Discovery V-Forum, a fully virtual conference, in April 2021. Delivering 2 days of top-level strategic content and the current scientific insights, networking, and discussion from leading global pharmaceuticals.

Join 150+ attendees to explore the latest trends & strategies within Discovery Research. This fully online event will be a mixture of on-demand and live sessions so you can join the best in class scientific discussions from the comfort of your home office. This year’s conference will highlight the challenges discovery pipelines have faced due to COVID-19 and put a spotlight on the adoption of technology to combat these.

The All-New Agenda

AI In Drug Discovery

  • Application of Artificial Intelligence in COVID-19 Drug Repurposing
  • AI Driven Drug Discovery Models

Lead Generation Strategies

  • Hit Triage and Validation Strategies
  • Chromatography-Free High-Throughput Mass Spectrometry

Biologics Drug Discovery

  • The Next Generation of Biological Therapeutics – A Systematic Review
  • Developing Cyclic Peptides into Therapies

Fragment - Based Drug Discovery

  • 3D Scaffolds for Fragment-Based Drug Discovery
  • Implications of Structural Fluctuations for Fragment-Based Drug Design

Preclinical Strategies, Models And Tools In Oncology

  • Oncology Treatment in the Era of COVID-19
  • Preclinical Collaboration to Improve Oncology Drug Development

COVID-19 Spotlight: RNA As A Drug Target

  • Current Approaches for the Analysis of SARS-CoV-2 RNA Polymerase as a Potential Drug Target
  • Small Molecule-RNA Targeting

Novel Drug Target Discovery & Validation

  • State-of-the-Art Chemoproteomic Technologies
  • Advancements in Genome Editing

Advances In Medical Chemistry

  • The Medical Chemistry in the Era of Machines and Automation
  • The Evolving Role of Machine Learning and AI in Computational Chemistry

Advances In Drug Design

  • Computer Aided Drug Design Approaches against SARS-CoV-2
  • Deep Generative Models for Target-Specific & Selective Drug Design

  • Bioinformatics
  • Principal Research Scientist
  • Translational Immunology
  • Medical Chemistry
  • Innovation
  • Research
  • R&D Senior Scientist
  • Preclinical Development
  • Computational Chemist
  • CSO
  • Data Scientist
  • Non-Clinical Development
  • Biology
  • Early Development
  • Non-Clinical Biostatistics
  • Intelligent Systems Laboratory
  • Chief Scientific Officer
  • Pharmaceutical Research
  • Discovery R&D
  • Senior Scientist
  • CTO
  • Analytical Sciences
  • Machine Learning Research
  • Translational oncology

  • Bioinformatics
  • Principal Research Scientist
  • Translational Immunology
  • Medical Chemistry
  • Innovation
  • Research
  • R&D Senior Scientist
  • Preclinical Development
  • Computational Chemist
  • CSO
  • Data Scientist
  • Non-Clinical Development
  • Biology
  • Early Development
  • Non-Clinical Biostatistics
  • Intelligent Systems Laboratory
  • Chief Scientific Officer
  • Pharmaceutical Research
  • Discovery R&D
  • Senior Scientist
  • CTO
  • Analytical Sciences
  • Machine Learning Research
  • Translational oncology

CAROLINE BARELLE

Chief Executive Officer and Founder
Elasmogen Ltd

DAN D. ARIDOR

Chairman of the Board, AEBI-Bio

DOMINGO GARGALLO-VIOLA

CEO, CSO
ABAC Therapeutics S.L

DR MICHAEL-ROBIN WITT

CEO, Gabather

ELANA HARITON GAZAL

Head of Pharmaceutical Research.
Neuroderm

ETIENNE DONCKELE

Senior Scientist - Deputy Head of Chemistry
Philochem

EYAL GREENBERG, PH.D., MBA

Chief Executive Officer
4C Biomed Services Ltd

FLORENT SAMAIN

Leader DNA-Encoded Chemical Library
Philochem

HIDEYOSHI FUJI

Manager
Astellas Pharma

IDDO WEINER

Director, Head of Software, BiomX

IDIT ESHKAR-OREN

Director Non-Clinical Safety, Pi Therapeutics

MANUELA MALLY

Director, Head of Research, GlycoEra AG.

NAMSHIK HAN, PHD

Head of Artificial Intelligence
Milner Therapeutics Institute, University of Cambridge

NICOLAS BERY

Senior Postdoctoral Scientist
University Of Oxford, MRC Weatherall Institute Of Molecular Medicine

OREN HERHSKOVITZ

CEO, Enlivex Therapeutics

PETER HENSTOCK

Machine Learning & AI Technical Lead: Combine AI, Software Engineering, Statistics & Visualization
Pfizer

PHILIPPE MOINGEON

Head of Therapeutic Area Immuno-Inflammation.
Servier Pharmaceuticals

RAFAEL DEPETRIS

Principal Scientist II, Lead of Structure Based Drug Design
Kadmon Holdings, Inc.

RAJKUMAR GANESAN

Head - Biologics Discovery, Alector

ROBERT SHORR

CEO, Cornerstone Pharmaceuticals

SARA COLOMBETTI

Global Head of Oncology Discovery Pharmacology
Roche Innovation Center Zurich

SHRUTHI BHARADWAJ, Ph.D

Data Science & A.I Advisor, Chief Digital Office
Novartis

TEODOR AASTRUP

Founder and CEO, Attana

TOMI SAWYER

Chief Drug Hunter & President
Maestro Therapeutics

admescope

Platinum

attana

Platinum

evitria

Platinum

e-Zyvec

Platinum

Reaction Biology

Platinum

Selvita

Platinum

CAROLINE BARELLE

Chief Executive Officer and Founder
Elasmogen Ltd

DAN D. ARIDOR

Chairman of the Board, AEBI-Bio

DOMINGO GARGALLO-VIOLA

CEO, CSO
ABAC Therapeutics S.L

DR MICHAEL-ROBIN WITT

CEO, Gabather

ELANA HARITON GAZAL

Head of Pharmaceutical Research.
Neuroderm

ETIENNE DONCKELE

Senior Scientist - Deputy Head of Chemistry
Philochem

EYAL GREENBERG, PH.D., MBA

Chief Executive Officer
4C Biomed Services Ltd

FLORENT SAMAIN

Leader DNA-Encoded Chemical Library
Philochem

HIDEYOSHI FUJI

Manager
Astellas Pharma

IDDO WEINER

Director, Head of Software, BiomX

IDIT ESHKAR-OREN

Director Non-Clinical Safety, Pi Therapeutics

MANUELA MALLY

Director, Head of Research, GlycoEra AG.

NAMSHIK HAN, PHD

Head of Artificial Intelligence
Milner Therapeutics Institute, University of Cambridge

NICOLAS BERY

Senior Postdoctoral Scientist
University Of Oxford, MRC Weatherall Institute Of Molecular Medicine

OREN HERHSKOVITZ

CEO, Enlivex Therapeutics

PETER HENSTOCK

Machine Learning & AI Technical Lead: Combine AI, Software Engineering, Statistics & Visualization
Pfizer

PHILIPPE MOINGEON

Head of Therapeutic Area Immuno-Inflammation.
Servier Pharmaceuticals

RAFAEL DEPETRIS

Principal Scientist II, Lead of Structure Based Drug Design
Kadmon Holdings, Inc.

RAJKUMAR GANESAN

Head - Biologics Discovery, Alector

ROBERT SHORR

CEO, Cornerstone Pharmaceuticals

SARA COLOMBETTI

Global Head of Oncology Discovery Pharmacology
Roche Innovation Center Zurich

SHRUTHI BHARADWAJ, Ph.D

Data Science & A.I Advisor, Chief Digital Office
Novartis

TEODOR AASTRUP

Founder and CEO, Attana

TOMI SAWYER

Chief Drug Hunter & President
Maestro Therapeutics

admescope

Platinum

attana

Platinum

evitria

Platinum

e-Zyvec

Platinum

Reaction Biology

Platinum

Selvita

Platinum

Stay Updated

Stay Updated

Copyright © 2020 Industry Events. All rights reserved. Site credit.